Bruker (BRKR) Income from Non-Controlling Interests (2010 - 2026)
Bruker's (BRKR) quarterly Income from Non-Controlling Interests came in at $1.1 million in Q2 2026, up 132.35% on a YoY basis from $473417.7 in Q2 2025, and down 15.38% quarter-over-quarter from $1.3 million in Q1 2026.
Powered by 
Analysis
Bruker (BRKR) Income from Non-Controlling Interests (2010 - 2026) Analysis & Trends
Bruker (BRKR) has reported Income from Non-Controlling Interests for 17 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Income from Non-Controlling Interests rose 132.35% year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2026 stood at $8.7 million (up 297.73% YoY), and the FY2025 full-year result was $2.3 million, up 228.57% from the prior year.
- Income from Non-Controlling Interests fell to $1.1 million in Q2 2026 per BRKR's latest filing, from $1.3 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $5.2 million in Q4 2025 and bottomed at -$3.4 million in Q2 2025.
- Historically, Income from Non-Controlling Interests has averaged $547058.8 across 5 years, with a median of $600000.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Income from Non-Controlling Interests slumped 200.0% in 2024, then surged 2500.0% in 2025.
- Over 5 years, Income from Non-Controlling Interests stood at $3.2 million in 2022, then tumbled by 128.12% to -$900000.0 in 2023, then surged by 122.22% to $200000.0 in 2024, then soared by 2500.0% to $5.2 million in 2025, then sank by 78.85% to $1.1 million in 2026.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $1.1 million, $1.3 million, and $5.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | - |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | - |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | - |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | - |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 1.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 5.20 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | -3.40 Mn |
| Mar 31, 2025 | -600,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | -600,000.00 |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | -900,000.00 |
| Sep 30, 2023 | 600,000.00 |
| Jun 30, 2023 | 700,000.00 |
| Mar 31, 2023 | 900,000.00 |
| Dec 31, 2022 | 3.20 Mn |
| Sep 30, 2022 | -600,000.00 |
| Jun 30, 2022 | -500,000.00 |
| Mar 31, 2022 | 500,000.00 |
| Dec 31, 2021 | 300,000.00 |
| Sep 30, 2021 | 1.00 Mn |
| Jun 30, 2021 | 1.10 Mn |